Comprehensive pan-cancer analysis of RPRD1B as a promising diagnostic and prognostic biomarker. [PDF]
Tian Y, Wang X, Tang R, Wang X.
europepmc +1 more source
Cuproptosis as a novel predictor of immunotherapy response and shapes the immune landscape in pan-cancer analysis. [PDF]
Pan Y, Hu X, Cheng J.
europepmc +1 more source
Systematic Pan-Cancer Characterization of ST3GAL4 Reveals Its Prognostic and Immunologic Associations. [PDF]
Luo F, Sun X, Wu C, Tan J, Pan Y.
europepmc +1 more source
Pan-cancer signaling landscape linked to endothelial and immune Sphingosine-1-phosphate receptor 1 (S1PR1) expression. [PDF]
Torres-Santos Y +3 more
europepmc +1 more source
Identification of lncRNAs Indicating Immune Pathway Activity for Predicting Prognosis and Immunotherapy Response in Pan-Cancer. [PDF]
Xin M +11 more
europepmc +1 more source
FSCN1 drives sarcoma progression and immunosuppression revealed by pan-cancer analysis and functional assays. [PDF]
Xu L +7 more
europepmc +1 more source
Systematic identification of pan-cancer single-gene expression biomarkers in drug high-throughput screens. [PDF]
Kutkaite G +5 more
europepmc +1 more source
A Pan-Cancer Atlas of TIPE2 Identifies Its Association With the Tumor Immune Microenvironment, Prognosis, and Immunotherapeutic Potential. [PDF]
Cao H +6 more
europepmc +1 more source
Comprehensive prognostic and immune infiltration assessment of LGALS3BP in pan-cancer patients. [PDF]
Yun D, Mu Q, Li Y, Wang W, An R, Wang F.
europepmc +1 more source
DNA methylation biomarkers-based pan-cancer classifier: predictive modeling for cancer classification. [PDF]
Bińkowski J, Wojdacz TK.
europepmc +1 more source

